NorLevo (levonorgestrel) / ASKA Pharma, Nxera Pharma, Novartis, Perrigo Company - LARVOL DELTA

Hormonal IUD Shows Promise in Early Endometrial Cancer — Regression seen in 82% of women with precancerous lesions (MedPageToday) - "'One of the things that most interested me in this study is the remarkable weight loss that you saw across these various arms,' said SGO discussant Angeles Alvarez Secord, MD...'In my clinical experience and the research that we have conducted, it is very difficult for endometrial cancer patients to lose weight even when you do perform counseling, and most often these women continue to gain weight.'...'While the [pCR] results in the women with atypical endometrial hyperplasia were very reassuring, the findings in endometrial cancer were lower than what I expected,' added Alvarez Secord."

Media quote